Proyecto Identity: Identificación de pacientes por biometría de voz en farmacia externa hospitalaria.

[[Translated article]]Improving the Management and Follow-up of Atopic Dermatitis: A Delphi Process Report of Consensus Between Hospital Dermatologists and Pharmacists.

Herranz-Pinto P; (...); Tortajada Goitia B

Practice Guideline. 10.1016/j.ad.2023.07.008. 2023

• 
• 
• PlumX Metrics

  

  • Captures
    • Readers: 3
  • Social Media
    • Shares, Likes & Comments: 3

  see details

[Translated article] Cybersecurity: a priority for pharmacy services in the age of artificial intelligence

Marin, Cayetano M. Hernandez, Monte-Boquet, Emilio, Andres, Jose Luis Poveda

Editorial Material. 10.1016/j.farma.2024.08.009. 2024

[Translated article] Checklist for the pharmaceutical care of patients with interstitial lung disease (CheckEPID): A Delphi-based consensus.

Calvin-Lamas, Marta; (...); Ventayol Bosch, Pere

Article. 10.1016/j.farma.2023.09.004. 2023

• 
• PlumX Metrics

  

  • Captures
    • Readers: 10

  see details

[Translated article] Good humanisation practices in the healthcare of patients with rare diseases in Pharmacy Services

Company Albir MJ, Andrés JLP, Solsona MDE

Article. 10.1016/j.farma.2023.10.004. 2024

• 
• PlumX Metrics

  

  • Captures
    • Readers: 1

  see details

[Translated article] Medication reconciliation in pediatric hemato-oncologic patients: A multicenter study

Vendrell, Margarita Cuervas-mons; (...); Corro, Beatriz Garrido

Article. 10.1016/j.farma.2023.07.012. 2023

• 
• 
• PlumX Metrics

  

  • Captures
    • Readers: 14

  see details

[Translated article] New challenges in advanced therapies.

Megías-Vericat JE; (...); Poveda Andrés JL

Article. 10.1016/j.farma.2024.05.001. 2024

• 
• PlumX Metrics

  

  • Captures
    • Readers: 3

  see details

[Translated article] Pharmacokinetic-guided switching from standard half-life factor VIII to extended half-life pegylated factor VIII in haemophilia A therapy in clinical practice.

Chovi-Trull, Maria; (...); Andres, Jose Luis Poveda

Article. 10.1016/j.farma.2024.12.007. 2025

[Translated article] Real-world effectiveness and safety of nivolumab in patients with relapsed or refractory classical Hodgkin lymphoma.

Fernandez, Laura Lorente; (...); Andres, Jose Luis Poveda

Article. 10.1016/j.farma.2024.09.006. 2024

2022 update of the indicators for quality of care and pharmaceutical care for people living with human immunodeficiency virus.

Martin Conde MT; (...); Morillo-Verdugo, Ramon

Article. 10.1016/j.farma.2023.04.008. 2023

• 
• PlumX Metrics

  

  • Captures
    • Readers: 11

  see details
• 2

  

2022 update of the indicators for quality of care and pharmaceutical care for people living with human immunodeficiency virus.

Martin, Maria Teresa; (...); Morillo-Verdugo, Ramon

Article. 10.1016/j.farma.2023.01.007. 2023

• 
• 
• PlumX Metrics

  

  • Citations
    • Citation Indexes: 2
  • Captures
    • Readers: 43
  • Mentions
    • News Mentions: 1

  see details
• 2

  

A Qualitative Tool to Guide in the Interpretation of the Numerical Rating Scale for Pruritus Intensity in Patients with Atopic Dermatitis.

Figueras I; (...); Ortiz de Frutos FJ

Article. 10.2340/actadv.v104.18255. 2024

• 
• PlumX Metrics

  

  • Captures
    • Readers: 8
  • Mentions
    • News Mentions: 1

  see details

Analysis of the situation of pharmaceutical care for patients with immune-mediated inflammatory diseases before and after the COVID-19 pandemic.

Lopez Sanchez, Piedad; (...); Monte Boquet, Emilio

Article. 10.1016/j.farma.2024.10.001. 2024

Antimicrobial Defined Daily Dose in Neonatal Population: Validation in the Clinical Practice.

Villanueva-Bueno, Cristina; (...); Paediatric Antimicrobial Defined Daily Dose Study Group KiDDDs

Article. 10.3390/antibiotics12030602. 2023

• 
• 
• PlumX Metrics

  

  • Captures
    • Readers: 6
  • Mentions
    • Blog Mentions: 1
    • News Mentions: 1

  see details
• 1

  

Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA).

Pereyra-Rodríguez JJ; (...); Ortiz de Frutos FJ

Letter. 10.1111/jdv.19432. 2023

• 
• 
• 1

  

Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.

Montoro-Ronsano JB; (...); Soto-Ortega I

Article. 10.1016/j.farma.2023.01.003. 2023

Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.

Montoro-Ronsano, Jose Bruno; (...); Soto-Ortega, Inmaculada

Article. 10.1016/j.farma.2023.04.002. 2023

Consensus statement on the use of biosimilar drugs in immune-mediated diseases in Spain

Monte-Boquet, Emilio; (...); Sellas, Agusti

Article. 10.1016/j.reuma.2022.12.001. 2023

COST-EFFECTIVENESS ANALYSIS OF DIFELIKEFALIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE ASSOCIATED-PRURITUS IN SPAIN

Sanchez-Alvarez, Emilio E.; (...); Hernaez Colque, M.

Meeting Abstract. 2024

Cybersecurity, a priority for pharmacy services in the age of artificial intelligence.

Hernández Marín CM, Monte-Boquet E, Poveda Andrés JL

Editorial Material. 10.1016/j.farma.2024.08.001. 2024

Checklist for Pharmaceutical Care of the Patient with interstitial lung disease (CheckEPID): A Delphi-based consensus.

Calvin Lamas M; (...); Ventayol Bosch P

Article. 10.1016/j.farma.2023.06.010. 2023

• 
• 
• 2

  

Determining value in the treatment of activated PI3Kdelta syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders.

Abad, Maria Reyes; (...); Gil, Alicia

Article. 10.33393/grhta.2024.3041. 2024

• 
• PlumX Metrics

  

  • Citations
    • Citation Indexes: 1
  • Captures
    • Readers: 5
  • Mentions
    • News Mentions: 1

  see details
• 2

  

Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi-Criteria Decision Analysis

Silvestre, Juan Francisco; (...); Serra-Baldrich, Esther

Article. 10.1002/jvc2.275. 2024

Development and testing of a mobile app for systematic collection of patient-reported outcomes (PROs) in patients with hemophilia.

Megias-Vericat, J E; (...); Poveda Andres, J L

Letter. 10.1016/j.thromres.2024.109122. 2024

• 
• PlumX Metrics

  

  • Captures
    • Readers: 5

  see details

Elevating the Standard of Care for Patients with Psoriatic Arthritis: 'Calls to Action' from a Multistakeholder Pan-European Initiative.

Verbinnen I; (...); Helliwell PS

Article. 10.1007/s40744-024-00664-3. 2024

Genetic Variants Associated with Biological Treatment Response in Inflammatory Bowel Disease: A Systematic Review.

Plaza J; (...); Moret-Tatay I

Article. 10.3390/ijms25073717. 2024

• 
• 
• 6

  

Hereditary angioedema in Spain: medical care and patient journey.

Caballero, Teresa; (...); Zamora, Carolina

Article. 10.1186/s13023-024-03182-1. 2024

Improving the Management and Follow-up of Atopic Dermatitis: A Delphi Process Report of Consensus Between Hospital Dermatologists and Pharmacists.

Herranz-Pinto P; (...); Tortajada Goitia B

Practice Guideline. 10.1016/j.ad.2023.04.019. 2023

Inhaled aztreonam lysine in the management of Pseudomonas aeruginosa in patients with cystic fibrosis: real-life effectiveness.

Jimenez-Lozano, Ines; (...); Alvarez-Fernandez, Antonio

Article. 10.1136/ejhpharm-2023-003937. 2023

• 
• 1

  

Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis.

Pozo-Rosich P; (...); Irimia P

Article. 10.1186/s10194-024-01747-w. 2024

• 
• 
• 5

  

Isavuconazole Pharmacokinetics in Critically Ill Patients: Relationship with Clinical Effectiveness and Patient Safety.

Martin-Cerezuela, Maria; (...); Ramirez Galleymore, Paula

Article. 10.3390/antibiotics13080706. 2024

• 
• 2

  

Medication reconciliation at admission in paediatric patients with chronic illness: A multicentre study

Vendrell, Margarita Cuervas-Mons; (...); Marrodan, Belen Rodriguez

Article. 10.1016/j.anpedi.2023.10.004. 2023

Medication reconciliation on admission in paediatric chronic patients: A multicentre study.

Cuervas-Mons Vendrell M; (...); Rodríguez Marrodán B

Article. 10.1016/j.anpede.2023.11.008. 2023

Multicentre study of medication reconciliation in paediatric onco-hematology.

Cuervas-Mons Vendrell M; (...); Garrido Corro B

Article. 10.1016/j.farma.2023.06.004. 2023

New challenges of advanced therapies.

Megías-Vericat JE; (...); Poveda Andrés JL

Article. 10.1016/j.farma.2023.11.008. 2024

Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus

Solana-Altabella, Antonio; (...); Poveda-Andres, Jose Luis

Article. 10.1097/MD.0000000000032208. 2022

• 
• 
• 1

  

ODs with a positive TPR conclusion, not subject to a conditional approval, and approved without requering a pass would be more likely to be reimbursed in Spain.

Poveda JL; (...); Badia X

Article. 10.1186/s13023-022-02610-4. 2023

• 
• 
• 1

  

Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes

Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor

Review. 10.3390/biology12091159. 2023

• 
• 
• 4

  

OPTIMIZING MANAGEMENT AND OUTCOMES OF ACTIVATED PHOSPHOINOSITIDE 3-KINASE DELTA SYNDROME (APDS) IN SPAIN: BEWAYAPDS PROJECT

Flores-Moreno, S.; (...); Gil, A.

Meeting Abstract. 2024

Patient-reported outcome measures in severe asthma: an expert consensus.

Martínez-Moragón E; (...); Sánchez-Cuellar S

Article. 10.1080/02770903.2023.2297372. 2023

• 
• 
• 4

  

Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review.

Ballesta-Lopez, Octavio; (...); Poveda-Andres, Jose Luis

Article. 10.3390/ijms26041760. 2025

Presence of good humanization practices in the healthcare of patients with rare diseases in Pharmacy Services

Company Albir MJ, Poveda Andrés JL, Edo Solsona MD

Article. 10.1016/j.farma.2023.06.0131130. 2024

Telematic Interview in Telepharmacy: a comprehensive guide for pharmacotherapeutic follow-up and and informed drug delivery.

Barbadillo-Villanueva S; (...); Monte-Boquet E

Article. 10.1016/j.farma.2024.04.008. 2024

Telematic interview in telepharmacy: consensus document for farmacotherapeutic monitoring and informed drug delivery.

Barbadillo-Villanueva S; (...); Monte-Boquet E

Article. 10.1016/j.farma.2024.01.006. 2024

TELEPROM Psoriasis: Enhancing patient-centered care and health-related quality of life (HRQoL) in moderate-to-severe plaque psoriasis.

Mercadal-Orfila G; (...); Herrera-Pérez S

Article. 10.3389/fmed.2024.1465725. 2024

• 
• 
• 1

  

The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD).

Badia, Xavier; (...); Valles, Joan-Antoni

Article. 10.1186/s13023-024-03324-5. 2024

Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die.

Chovi-Trull, Maria; (...); Poveda-Andres, Jose Luis

Article. 10.1136/ejhpharm-2024-004184. 2024

• 
• 1

  

VALUE CRITERIA FOR OUTCOMES BASED MANAGED ENTRY AGREEMENT OF CAR-T IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) THROUGH MCDA

Poveda, J. L.; (...); Lizan, L.

Meeting Abstract. 2023